MARCELLO, RAFFAELLA
 Distribuzione geografica
Continente #
NA - Nord America 336
AS - Asia 208
EU - Europa 170
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 718
Nazione #
US - Stati Uniti d'America 335
CN - Cina 165
IE - Irlanda 80
SE - Svezia 62
TR - Turchia 26
SG - Singapore 14
FI - Finlandia 13
DE - Germania 6
EU - Europa 3
IN - India 3
CZ - Repubblica Ceca 2
BE - Belgio 1
BG - Bulgaria 1
CA - Canada 1
CI - Costa d'Avorio 1
FR - Francia 1
GB - Regno Unito 1
HR - Croazia 1
MD - Moldavia 1
RO - Romania 1
Totale 718
Città #
Chandler 123
Dublin 80
Beijing 49
Ashburn 37
Nanjing 25
Izmir 19
Shanghai 16
Princeton 15
Helsinki 13
Shenyang 13
Hebei 9
Wilmington 8
Kocaeli 7
Singapore 7
Tianjin 7
San Mateo 6
Washington 6
Kunming 5
Nanchang 5
Dearborn 4
Jiaxing 4
Bremen 3
Changsha 3
Guangzhou 3
Hefei 3
Jinan 3
Ningbo 3
Norwalk 3
Pune 3
Borås 2
Dallas 2
Grafing 2
Hangzhou 2
Olomouc 2
Wenzhou 2
Zhengzhou 2
Abidjan 1
Ann Arbor 1
Antwerp 1
Bordeaux 1
Cambridge 1
Chisinau 1
Edinburgh 1
Fremont 1
Jinhua 1
Las Vegas 1
Los Angeles 1
Prineville 1
Rockville 1
Sofia 1
Timisoara 1
Toronto 1
Xian 1
Zagreb 1
Totale 514
Nome #
P.05.11 CLINICAL USEFULNESS OF LACTOSE-RESTRICTED DIET IN POSITIVE QUICK LACTASE TEST PATIENTS: PROSPECTIVE 4 MONTHS STUDY 65
OC.18.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM ADMINISTRATION: A 6 MONTHS STUDY IN ATROPHIC GASTRITIS SUBJECTS 63
OC.07.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM® ADMINISTRATION: A 2 YEAR PROSPECTIVE STUDY IN PATIENTS WITH CHRONIC, ATROPHIC, BODY GASTRITIS 57
P.04.11 A NEW APPROACH TO DETECTION OF NON-RESPONDER PATIENTS IN GERD BY NON-INVASIVE MARKERS 53
P.08.3 ROLE OF THE COLON CANCER SCREENING PROGRAMME ON INFLAMMATORY BOWEL DISEASE NEW DIAGNOSIS. ONE YEAR EXPERIENCE IN AN ITALIAN NORTH-EAST AREA 53
OC.18.1 ARE ALL PATIENTS WITH HISTOLOGICAL DIAGNOSIS OF ATROPHIC GASTRITIS REALLY AT RISK OF DEVELOPING GASTRIC CANCER? ASSESSMENT OF GASTRIC ACID PRODUCTION BY CORRELATION BETWEEN MAXIMAL ACID OUTPUT AND PEPSINOGEN I 52
P.09.22 GASTROPANEL, A NON-INVASIVE, SAFE ENDOSCOPY METHOD: A PROSPECTIVE 1000 PATIENTS STUDY IN PRIMARY CARE SETTING 48
P.09.23 OVERLAP OF THREE PATHOLOGICAL CONDITIONS (HELICOBACTER PYLORI INFECTION, YELLOW STOMACH AND LACTOSE INTOLERANCE) IN PATIENTS WITH GASTROINTESTINAL DISORDERS 47
P.01.6 A 7 YEARS STUDY ON EPIDEMIOLOGIC ASPECTS OF INFLAMMATORY BOWEL DISEASE IN THE NORTH EAST OF ITALY 47
P.12.12 INTERMITTENT VERSUS EVERY-DAY MESALAZINE THERAPY IN PREVENTING COMPLICATIONS OF DIVERTICULAR DISEASE OF THE COLON: A LONG-TERM FOLLOW-UP STUDY 43
P.06.13 PRUCALOPRIDE FOR SEVERE COSTIPATION, HOW TO REACH THE SYMPTOM RESOLUTION AND HAVE TO MAINTAIN IT: A SIX-MONTHS EXPERIENCE 42
P.04.10 LOW LEVELS OF GASTRIN-17 AS A NON-INVASIVE MARKER OF GERD 42
P.09.1 RECOVERY OF GASTRIC FUNCTION AFTER HELICOBACTER PYLORI ERADICATION AND ACETIUM ADMINISTRATION: A 6 YEARS STUDY IN ATROPHIC GASTRITIS SUBJECTS 41
P.09.2 IS H. PYLORI ERADICATION USEFUL IN THE IMPROVEMENT OF DYSPEPSIA? A 15 YEARS STUDY 41
P.13.8 USEFULNESS OF CONVENTIONAL GASTROINTESTINAL ENDOSCOPY IN MANAGEMENT OF ANEMIA: A SINGLE CENTER RETROSPECTIVE ANALYSIS 39
Totale 733
Categoria #
all - tutte 2.991
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.991


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202088 0 48 2 0 2 3 4 0 1 18 10 0
2020/202110 0 0 1 0 0 0 0 0 2 7 0 0
2021/202253 0 0 0 2 10 2 0 3 3 6 0 27
2022/2023348 25 26 29 37 16 49 1 33 111 0 14 7
2023/202496 1 13 6 1 10 31 0 5 3 6 13 7
2024/202512 9 3 0 0 0 0 0 0 0 0 0 0
Totale 733